Product Information

AMLODIPINE-ATORVAST 5-10 MG is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $1.0923 per EA under NDC 00378451393. Its NADAC has been published 597 times since Jun 10, 2015.

FDA first approved this application on Nov 29, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-ATORVAST 5-10 MG

Amlodipine and atorvastatin
$1.0923per EA

Strength

5; 10 mg/1; mg/1

NDC

00378451393

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA200465

FDA Approved

11/29/2013

TE Code

AB

On Market Since

4/2/2015

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines
HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for AMLODIPINE-ATORVAST 5-10 MG has been published 597 times since Jun 10, 2015, and over the history we have for it it has declined 73.4%. The table below summarizes its recorded NADAC range and movement.

Current price$1.0923 per EA
All-time high$4.7188 (Nov 11, 2015)
All-time low$0.7019 (Jul 17, 2024)
52-week high$1.2974
52-week low$1.0211
Median price$2.4714
Average price$2.3897
Largest weekly change+78.9% (Oct 19, 2022)
Weeks tracked597
Tracking sinceJun 10, 2015

Price History

1W

0.0%

1M

+1.0%

3M

+5.7%

6M

+5.8%

1Y

-20.6%

3Y

-62.5%

5Y

-44.7%

All

-73.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Amlodipine and atorvastatin market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of AMLODIPINE-ATORVAST 5-10 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-ATORVAST 5-10 MG, manufactured by Mylan Pharmaceuticals Inc., is $1.0923 per EA (NDC 00378451393), effective Nov 11, 2026.

How has the price of AMLODIPINE-ATORVAST 5-10 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-ATORVAST 5-10 MG has declined 73.4%. It has been tracked across 597 weekly CMS publications since Jun 10, 2015.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-ATORVAST 5-10 MG?

Since Jun 10, 2015, the NADAC for AMLODIPINE-ATORVAST 5-10 MG has ranged from a low of $0.7019 (Jul 17, 2024) to a high of $4.7188 (Nov 11, 2015), with a median of $2.4714 per EA.

Are there cheaper alternatives to AMLODIPINE-ATORVAST 5-10 MG?

No other NADAC-published product currently shares the active ingredient and strength of AMLODIPINE-ATORVAST 5-10 MG in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures AMLODIPINE-ATORVAST 5-10 MG?

AMLODIPINE-ATORVAST 5-10 MG (NDC 00378451393) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.